🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy, safety and immunogenicity of different f...
Status
Completed
Location
George Washington University
Start Date
2018-03-01
Trial ID
NCT03172975
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Alabama CRS
Start Date
2020-01-13
Trial ID
NCT04177355
This two part study will evaluate the safety and immunogenicity of two form...
Status
Completed
Location
Americaninhas Vaccine Center
Start Date
2011-11
Trial ID
NCT01261130
This study is designed to evaluate the safety, reactogenicity, and immunoge...
Status
Completed
Location
Children's National Medical Center
Start Date
2012-05
Trial ID
NCT01385189
This protocol is for a phase 1, randomized, single-blinded study to evaluat...
Status
Completed
Location
Rockefeller University
Start Date
2012-09
Trial ID
NCT01864876
Treatments Being Tested
This is a Phase I, first-in-human study of a vaccine against S. mansoni inf...
Status
Completed
Location
Baylor College of Medicine - Molecular Virology and Microbiology
Start Date
2015-02-04
Trial ID
NCT02337855
Treatments Being Tested
Na-GST-1 and Na-APR-1 are proteins expressed during the adult stage of the ...
Status
Completed
Location
Centre de Recherches Médicales de Lambaréné Albert Schweitzer Hospital
Start Date
2014-11
Trial ID
NCT02126462
Treatments Being Tested
The potential HIV vaccine has two components: a protein immunogen based on ...
Status
Completed
Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Start Date
2013-10
Trial ID
NCT01966900
Treatments Being Tested
Na-GST-1 and Na-APR-1 are proteins expressed during the adult stage of the ...
Status
Completed
Location
Americaninhas Vaccine Center
Start Date
2016-01
Trial ID
NCT02476773